Jung S Chen

Title: Innovations of Jung S Chen in Antibody Development

Introduction

Jung S Chen is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of immunology, particularly in the development of antibodies. His innovative approach has led to advancements that could impact medical diagnostics and treatments.

Latest Patents

Jung S Chen holds a patent for a method of obtaining antibodies. This patent describes a process for obtaining antibodies specific to glycosylated hemoglobin, which are substantially free of cross-reactivity with nonglycosylated forms of hemoglobin. The method involves administering a synthetic antigen to a host animal. The antigen comprises a glycosylated synthetic peptide with an amino acid sequence corresponding to the NH.sub.2 -terminus of the .beta.-chain of hemoglobin. The peptide consists of a sequence of between four and ten amino acids, preferably seven, and is conjugated with glucose and a protein, which is typically an immunoglobulin foreign to the host animal. This innovative method has the potential to enhance the specificity and efficacy of antibody-based diagnostics.

Career Highlights

Jung S Chen is associated with Sherwood Medical Company, where he continues to apply his expertise in antibody development. His work has contributed to the company's reputation for innovation in medical technology.

Collaborations

Jung has collaborated with notable colleagues, including Louis M Mezei and John J Huang. These collaborations have fostered a productive environment for research and development in the field of immunology.

Conclusion

Jung S Chen's contributions to antibody development exemplify the impact of innovative thinking in medical science. His patent for a method of obtaining specific antibodies showcases his commitment to advancing healthcare solutions.